Partial Virological Response after 2 Years of Entecavir Therapy Increases the Risk of Hepatocellular Carcinoma in Patients with Hepatitis B Virus-Associated Cirrhosis

: The clinical significance of partial virological response (PVR) in patients undergoing antiviral therapy is not well known. This study investigated whether PVR after 2 years of entecavir (ETV) therapy is associated with hepatocellular carcinoma (HCC) development in cirrhotic patients. A total of 4...

Celý popis

Podrobná bibliografia

Vydané v:	Gut and liver Ročník 15; číslo 3; s. 430 - 439
Hlavní autori:	Shin, Seung Kak, Yim, Hyung Joon, Kim, Jeong Han, Lee, Chan Uk, Yeon, Jong Eun, Suh, Sang Jun, Jung, Young Kul, Kim, Yun Soo, Kim, Ju Hyun, Kwon, Oh Sang
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	Korea (South) Editorial Office of Gut and Liver 15.05.2021 Gastroenterology Council for Gut and Liver 거트앤리버 소화기연관학회협의회
Predmet:	entecavir hepatitis b virus hepatocellular carcinoma liver cirrhosis Original partial virological response 내과학 Partial virological response Hepatocellular carcinoma Hepatitis B virus Liver cirrhosis Entecavir
ISSN:	1976-2283, 2005-1212, 2005-1212
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!